Tranzactioneaza Milestone Pharmaceuticals (US.MIST) - 1.27 USD (%) Tranzactioneaza
1D
1W
1M
3M
6M
1Y
5Y
Max
Indici
Descriere companie
Milestone Pharmaceuticals Inc. (https://milestonepharma.com/) is a biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is self-administered by patients. The Company is developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF) and rapid ventricular rate, and other cardiovascular indications.